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Abstract
Mycobacterium tuberculosis synthesizes intra- and extracellular α-glucans that were
believed to originate from separate pathways. The extracellular glucose polymer is the main
constituent of the mycobacterial capsule that is thought to be involved in immune evasion
and virulence. However, the role of the α-glucan capsule in pathogenesis has remained
enigmatic due to an incomplete understanding of α-glucan biosynthetic pathways prevent-
ing the generation of capsule-deficient mutants. Three separate and potentially redundant
pathways had been implicated in α-glucan biosynthesis in mycobacteria: the GlgC-GlgA,
the Rv3032 and the TreS-Pep2-GlgE pathways. We now show that α-glucan in mycobacte-
ria is exclusively assembled intracellularly utilizing the building block α-maltose-1-phos-
phate as the substrate for the maltosyltransferase GlgE, with subsequent branching of the
polymer by the branching enzyme GlgB. Some α-glucan is exported to form the α-glucan
capsule. There is an unexpected convergence of the TreS-Pep2 and GlgC-GlgA pathways
that both generate α-maltose-1-phosphate. While the TreS-Pep2 route from trehalose was
already known, we have now established that GlgA forms this phosphosugar from ADP-glu-
cose and glucose 1-phosphate 1000-fold more efficiently than its hitherto described glyco-
gen synthase activity. The two routes are connected by the common precursor ADP-
glucose, allowing compensatory flux from one route to the other. Having elucidated this
unexpected configuration of the metabolic pathways underlying α-glucan biosynthesis in
mycobacteria, anM. tuberculosis double mutant devoid of α-glucan could be constructed,
showing a direct link between the GlgE pathway, α-glucan biosynthesis and virulence in a
mouse infection model.
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Author Summary
Capsule formation is critical for the virulence of many bacterial and fungal pathogens.
Mycobacterium tuberculosis cells are known to be surrounded by a capsule layer that is
mainly composed of an α-glucan glucose polymer that resembles glycogen. Progress in
understanding its role in the virulence of this important human pathogen has been held
back by a lack of knowledge of its biosynthesis, preventing the generation of α-glucan-defi-
cient mutants that could be tested in animal infection models. In this work, we unraveled
an unexpected metabolic network configuration revealing the exclusive production of
both intracellular and capsular α-glucans by the maltosyltransferase GlgE in mycobacteria.
GlgE polymerizes an α-maltose 1-phosphate building block, which is generated by two
alternative pathways that are connected by a common intermediate allowing rechanneling
of flux from one route to the other. Elucidation of this unexpected configuration of the
metabolic pathways underlying α-glucan biosynthesis allowed the rational construction of
anM. tuberculosismutant strain devoid of α-glucan, showing a direct link between the
GlgE pathway, α-glucan biosynthesis and virulence in a mouse infection model.
Introduction
More than 100 years after its discovery by Robert Koch,Mycobacterium tuberculosis, the etio-
logic agent of tuberculosis, still remains an unresolved global public health threat. New and
more effective chemotherapies for the treatment of tuberculosis are urgently required. Findings
in recent years suggest that α-glucan biosynthesis inM. tuberculosismay be an attractive pro-
cess that offers several vulnerable steps that could be exploitable in the development of novel
treatment options. Many bacteria produce α-1,4/α-1,6-glucan. However, while this glucose
polymer is typically assembled intracellularly in a glycogen-like storage form,M. tuberculosis
also deposits α-glucan extracellularly as a major component of the capsule [1, 2]. Anecdotal
reports have suggested the presence of a capsular layer surrounding mycobacteria for a long
time [3–5], but only recently has this layer been visualized in a near native state [6]. In vitro
experiments using purified capsular α-glucan demonstrated that it can interact with comple-
ment receptor 3, thus mediating binding ofM. tuberculosis to phagocytic cells [1, 7]. Capsular
α-glucan also blocks dendritic cell functions [8] and interacts with the C-type lectin receptor
DC-SIGN [9]. Furthermore, consistent with the general importance of the capsule for virulence
of many bacterial and fungal pathogens, anM. tuberculosismutant with a somewhat reduced
amount of capsular α-glucan showed impaired virulence [10]. Collectively, these findings indi-
cate that capsular α-glucans may be important forM. tuberculosis pathogenesis by interacting
with mammalian host cells and influencing the immune response toM. tuberculosis. However,
its precise role in virulence is unclear because the genes involved in its biosynthesis and export
have not been conclusively elucidated, precluding the generation of capsule-deficient mutants.
The properties of intracellular (i.e. cytosolic) α-glucan (often referred to as glycogen) and
extracellular (i.e. capsular) α-glucan from mycobacteria are very similar [10–13], suggesting a
common biosynthetic origin. Most bacterial species are believed to employ the classical
GlgC-GlgA pathway for the formation of glycogen-like α-glucans [14]. The first step in this
pathway is the formation of ADP-glucose from glucose 1-phosphate by the ADP-glucose pyro-
phosphorylase GlgC. Subsequently, ADP-glucose is polymerized to give linear α-1,4-glucans by
the glycogen synthase GlgA. Finally, the branching enzyme GlgB introduces α-1,6-branches.
However, in contrast to this general scheme, α-glucan biosynthesis inM. tuberculosis exhibits
increased complexity because two additional pathways appear to be involved (S1 Fig). In the
α-Glucan Biosynthesis inMycobacterium tuberculosis
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first alternative pathway, the glucosyltransferase Rv3032 is thought to synthesize linear α-
1,4-glucan by utilizing both UDP-glucose and ADP-glucose as activated donor substrates. This
glycosyltransferase has been reported to contribute to the production of higher-molecular
weight α-glucans inM. tuberculosis. However, its main role appears to be the formation of spe-
cialized oligomeric glucan derivatives, known as methylglucose lipopolysaccharides (MGLPs)
[15]. The second alternative pathway is the recently discovered TreS-Pep2-GlgE pathway,
which converts the abundant disaccharide trehalose into glucan polymers in four steps [16].
First, trehalose is isomerized to maltose by trehalose synthase TreS [17–19] with subsequent
phosphorylation by maltokinase Pep2 to give maltose 1-phosphate (M1P) [19–21]. The phos-
phosugar M1P serves as the substrate for the key enzyme of this pathway, the maltosyltransfer-
ase GlgE, which transfers maltosyl units from the donor substrate M1P to the non-reducing end
of α-glucan acceptors molecules, leading to linear α-1,4-chain elongation [22, 23]. Finally, the
linear α-1,4-glucans are branched with α-1,6-linkages by the branching enzyme GlgB [13, 16].
The co-existence of three possible routes for synthesizing α-glucans in mycobacteria is
unprecedented and raises the questions whether they are functionally redundant in the biosyn-
thesis of α-glucan, or whether each is dedicated to the production of either intracellular glyco-
gen-like material, capsular α-glucan or MGLPs. In this study, we therefore investigated how
these three alternative pathways contribute to the production of intracellular and capsular α-
glucans in mycobacteria. Employing comprehensive genetic manipulation of mycobacteria
combined with metabolic analyses of mutant strains and enzyme characterization, we revealed
an intricate and unexpected convergence of the TreS-Pep2-GlgE and the GlgC-GlgA pathways
in α-glucan biosynthesis as they both produce the M1P building block required for α-glucan
production by the key enzyme GlgE. Unravelling the configuration of the metabolic pathways
underlying α-glucan biosynthesis enabled the generation of α-glucan-deficient mutant strains
for the first time, allowing the study of the link between the GlgE pathway, the formation of α-
glucan and the virulence ofM. tuberculosis in an animal model.
Results
An alternative route for M1P formation inMycobacterium smegmatis
The maltosyltransferase GlgE (systematic name α-maltose 1-phosphate:(1!4)-α-D-glucan 4-
α-D-maltosyltransferase) is unusual in that a phosphosugar, M1P, serves as the activated
donor substrate. By contrast, most known glycosyltransferases rely on nucleotide-bound sugars
as donor substrates. The only pathway known so far for the synthesis of M1P uses the abun-
dant intracellular sugar trehalose (α,α-1,1-diglucose), which is isomerized to maltose (α-
1,4-diglucose) by trehalose synthase TreS [17–19], followed by ATP-driven phosphorylation of
maltose to M1P catalyzed by maltokinase Pep2 [19–21]. Consequently, M1P formation has
been reported to be prevented by blocking TreS or Pep2, e.g. inM. smegmatis ΔglgE(u) ΔtreS or
ΔglgE(u) Δpep2 double mutants [16]. These data suggested the only route to M1P inM. smeg-
matis and other mycobacteria is through the TreS-Pep2 pathway from trehalose [16]. We have
now analyzed extracts of theM. smegmatis ΔglgE(u) Δpep2 double mutant using a more sensi-
tive method (1H-NMR spectroscopy instead of thin-layer chromatography, TLC), and were
surprised to detect small amounts of M1P, despite the lack of Pep2 (Fig 1A). Mass spectrome-
try also confirmed the presence of an ion consistent with the presence of M1P.
Next, DNA microarray analyses were performed in order to find clues to explain the forma-
tion of M1P. We observed that the glgC gene in theM. smegmatis ΔglgE(u) Δpep2mutant was
downregulated compared with the parental strain control (4.83-fold), suggesting a stable, inad-
vertent spontaneous mutation of this locus. We therefore PCR-amplified the glgC locus and
sequenced it. This revealed an intrachromosomal IS element mobilization had occurred in this
α-Glucan Biosynthesis inMycobacterium tuberculosis
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strain with insertion of IS1096 10 bp upstream of the ATG start codon of the glgC gene, which
likely impaired gene expression. This means that theM. smegmatis strain de facto represented
a ΔglgE(u) Δpep2 glgC:IS1096 triple mutant. It is likely that the observed IS element mobiliza-
tion was a result of M1P toxicity caused by glgE gene deletion, maybe providing a mechanism
to suppress M1P stress. We thus complemented the defective glgC gene in theM. smegmatis
ΔglgE(u) Δpep2 glgC:IS1096mutant by heterologous expression of theM. tuberculosis glgC
gene (Rv1213). To our surprise, we found that this “repair” of the glgC locus strongly enhanced
Fig 1. Evidence for an alternative route to M1P inM. smegmatis independent of TreS-Pep2 and trehalose. (A)
Heterologous expression of theM. tuberculosis glgC gene (Rv1213) restores M1P accumulation in theM. smegmatis ΔglgE
Δpep2 double mutant harboring a spontaneous IS1096 element insertion in the endogenous glgC locus (i.e.M. smegmatis
ΔglgE Δpep2 glgC:IS1096). Equivalent quantities of crude extracts ofM. smegmatis strains were analyzed using 1H NMR
spectroscopy. The assignment of the peaks was based on our previous studies [16, 18]. (B) Hot water extracts from 1 ml culture
aliquots ofM. smegmatis strains (normalized to OD600 nm = 0.5) were analyzed by TLC, demonstrating M1P accumulation in
theM. smegmatis ΔglgE Δpep2 glgC:IS1096 strain expressing theM. tuberculosis glgC gene (Rv1213). M1P and trehalose
(5 μg each) were used as standards. (C)M. smegmatis Δpep2(u) ΔglgE and ΔtreS(u) ΔglgE double mutants accumulate M1P.
TLC analysis was performed as described in (B). (D) TheM. smegmatis Δpep2(u) ΔglgEmutant is trehalose resistant despite
accumulating M1P, indicating trehalose-independent M1P formation. Strains were grown on Middlebrook 7H10 agar plates
with or without 1 mM trehalose and incubated at 37°C for 3 days. (E) Conditional silencing of the glgE gene inM. smegmatis
mutant strains reveals the requirement of GlgC and GlgA for the alternative route to M1P synthesis. Cells of the indicated
conditional c-glgE-tet-off mutant strains were cultivated for 24 h with or without 1 μg ml-1 ATc as indicated, and hot water
extracts from 1 ml culture aliquots (normalized to OD600 nm = 0.5) were analyzed by TLC.
doi:10.1371/journal.ppat.1005768.g001
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M1P accumulation, as revealed by 1H-NMR (Fig 1A) and TLC analyses (Fig 1B), even though
M1P synthesis by Pep2 was not possible. Next, we corroborated this result by re-generatingM.
smegmatis double mutants by first deleting either the treS or pep2 gene, followed by deletion of
the glgE gene, in order to minimize any potential M1P stress to the cells. The re-generatedM.
smegmatis Δpep2(u) ΔglgE and ΔtreS(u) ΔglgE double mutants initially accumulated substantial
amounts of M1P as revealed by TLC analysis (Fig 1C), before rapid spontaneous suppressor
mutations occurred during sub-culturing likely due to insertional mutagenesis within the glgC
locus as revealed by diagnostic PCR. Nevertheless, despite M1P accumulation, theM. smegma-
tis Δpep2(u) ΔglgE double mutant was still resistant to trehalose (Fig 1D), in contrast to theM.
smegmatis ΔglgE single mutant which is sensitive due to M1P hyperaccumulation in presence
of trehalose [24]. This demonstrated that conversion of trehalose to M1P was efficiently
blocked in this strain and that M1P synthesis must have occurred through a route independent
of trehalose as a precursor.
GlgC and GlgA are involved in the alternative route to M1P inM.
smegmatis
As described above, deletion of the glgE gene causes genetic instability due to the toxicity of
M1P, complicating the analysis of genes involved in alternative routes to M1P. We therefore
established conditional glgE silencing inM. smegmatis in various genetic backgrounds in order
to allow M1P accumulation only under controlled conditions. For this, the glgE gene was
brought under control of a repressible promoter enabling gene silencing in the presence of
anhydrotetracycline (ATc) (i.e. a tet-off system). Silencing of glgE in the conditionalM. smeg-
matis c-glgE-tet-off mutant in presence of ATc resulted in M1P accumulation thereby repro-
ducing the initial phenotype of theM. smegmatis ΔglgE gene deletion mutant (Fig 1E). Next,
we analyzed the effect of conditional glgE gene silencing in variousM. smegmatismutant back-
grounds. As expected from our analysis above, glgE silencing in theM. smegmatis ΔtreS(u) c-
glgE-tet-off mutant resulted in M1P accumulation, as revealed by TLC (Fig 1E). By contrast,
synthesis of this phosphosugar was completely blocked in theM. smegmatis ΔtreS(u) ΔglgC(u)
c-glgE-tet-off strain. This corroborated our findings with the glgC suppressor mutation.
The phenotypes of the mutant strains implied that either GlgC or a downstream enzyme
could produce M1P. It has already been shown that GlgC fromM. tuberculosis efficiently con-
verts glucose 1-phosphate (G1P) and ATP to ADP-glucose and pyrophosphate [25] with no
indication of M1P being formed, according to 1H NMR spectroscopy. Another enzyme was
therefore likely to be responsible for the formation of M1P. Since GlgC produces the ADP-glu-
cose donor substrate for glycogen synthase GlgA, we then tested the involvement of GlgA in
M1P synthesis. As for glgC, inactivation of the glgA gene fully abolished M1P production in the
M. smegmatis ΔtreS(u) ΔglgA(u) c-glgE-tet-off strain upon glgE silencing (Fig 1E). These obser-
vations demonstrate that the alternative route to M1P synthesis inM. smegmatis requires both
ADP-glucose production by GlgC as well as GlgA enzyme activity.
GlgP is not involved in the alternative route to M1P synthesis
Since GlgA is believed to be a glycogen synthase, we initially hypothesized that M1P produc-
tion might arise through the phosphorolysis of α-glucans produced by the GlgC-GlgA path-
way. GlgP is annotated as a glycogen phosphorylase that generates G1P. Since the gene of the
glycogen phosphorylase GlgP is clustered with glgE, we speculated that GlgP could perhaps
generate M1P instead. However, recombinantM. tuberculosis GlgP was only capable of form-
ing G1P from glycogen and inorganic phosphate with no indication of M1P being formed,
according to 1H NMR spectroscopy (S2A Fig). Furthermore, silencing of glgE in the absence of
α-Glucan Biosynthesis inMycobacterium tuberculosis
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GlgP in the conditionalM. smegmatis ΔtreS(u) ΔglgP(u) c-glgE-tet-off mutant still resulted in
M1P accumulation (S2B Fig). These observations prove that GlgP is a G1P-producing glycogen
phosphorylase with no involvement in the alternative route to M1P production.
Mycobacterial GlgA is an M1P synthesizing glucosyltransferase with low
glycogen synthase activity
GlgA homologues from microorganisms are assumed to be glycogen synthases capable of elon-
gating the non-reducing ends of glycogen using ADP-glucose as a donor (EC 2.4.1.21 ADP-α-
D-glucose:(1!4)-α-D-glucan 4-α-D-glucosyltransferase) [26]. Indeed, such activity has been
reported forM. tuberculosis GlgA [25]. We confirmed that the enzyme is capable of catalyzing
this reaction with rabbit liver glycogen using a spectrophotometric assay that monitors the for-
mation of ADP (Table 1). The kcat (0.090 ± 0.007 s
-1) was consistent with values reported previ-
ously (0.15 ± 0.01 s-1) [25]. However, such values are extremely low compared with those
associated with bona fide glycogen synthases (e.g. human glycogen synthase 18.7 ± 0.3 s-1 [27];
E. coli glycogen synthase 694 ± 28 s-1 [28]). We therefore repeated the experiment with some
bacterial α-glucan isolated from Streptomyces venezuelae [13, 29], which also belongs to the
order Actinomycetales. However, the value of kcat was even lower at 0.014 ± 0.008 s
-1. Consis-
tent with this, the specific activity of theM. smegmatis enzyme has been reported to be of the
same order with glycogen isolated fromM. smegmatis [30]. These rates would appear to be too
low to be physiologically relevant [31], implying GlgA can play only a minor direct role for α-
glucan formation inM. tuberculosis.
In light of the low glycogen synthase activity and its involvement in the alternative route to
M1P, we then tested whether GlgA might be capable of synthesizing M1P directly using ADP-
glucose as a donor with G1P as an acceptor (Fig 2A). Using NMR spectroscopy, it was immedi-
ately apparent that GlgA consumed ADP-glucose (double doublet at ~5.5 ppm) with the con-
comitant formation of a product with an α-1,4 linkage (doublet at ~5.32 ppm). Integration of
peaks at the end of the reaction suggested the equilibrium position was ~1:8 in favour of the
formation of the α-1,4 linkage from the nucleotide diphospho sugar. This is consistent with the
thermodynamics of equivalent chemical equilibria [23]. The resonance associated with the
phosphorylated α-anomeric position of G1P remained unchanged (double doublet at
~5.36 ppm) and yet no new reducing ends associated with glucose, maltose or higher oligomers
were liberated (~5.15 ppm). Given that the resonance of the anomeric position of G1P is essen-
tially identical to the corresponding position of M1P [16], it can be deduced that the product of
the reaction was M1P (Fig 2B). High resolution mass spectrometry confirmed the presence of
an ion consistent with M1P and the absence of ions associated with maltotriose phosphate or
any higher oligomer (Fig 2C).
The substrate specificity was then explored further. A number of potential acceptors (1
mM) were tested using NMR spectroscopy to monitor the loss of ADP-glucose. The relative
activities were G1P> glycogen>maltodextrin>maltoheptaose. No activity was detected
with either glucose (up to 10 mM), glucose 6-phosphate, maltotetraose or isopannose. The lack
Table 1. GlgA activity with glycogen and α-glucan. Michaelis-Menten constants ± SE for recombinantM. tuberculosisGlgA with rabbit liver glycogen and
S. venezuelae α-glucan were determined in triplicate in the presence of 1 mM ADP-glucose by monitoring the production of ADP with a spectrophotometric
assay.
Acceptor kcat (s-1) Km (mgml-1) Vmax (U mg-1)
Rabbit liver glycogen 0.090 ± 0.007 0.9 ± 0.2 0.12 ± 0.01
S. venezuelae α-glucan 0.014 ± 0.008 0.4 ± 0.1 0.02 ± 0.01
doi:10.1371/journal.ppat.1005768.t001
α-Glucan Biosynthesis inMycobacterium tuberculosis
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Fig 2. Mycobacterial GlgA is an M1P synthesizing glucosyltransferase. (A) The preferred reaction catalyzed
by GlgA fromM. tuberculosis. (B) RecombinantM. tuberculosisGlgA converts ADP-glucose and G1P to M1P. 1H
NMR spectroscopy was used to monitor the anomeric protons of ADP-glucose and G1P (1 mM each) together with
signals associated with the product in the presence of GlgA. The spectra show the concomitant consumption of
ADP-glucose (~5.5 ppm) and appearance of resonances consistent with the formation of α-1,4 glycosidic linkages
(~5.32 ppm). Given the lack of any resonances associated with free reducing ends (~5.1 ppm) and the retention of
those associated with an α-glucosyl phosphate residue (~5.36 ppm), these observations are consistent with the
formation of M1P. (C) Mass spectrometry of the product of theM. tuberculosisGlgA reaction with ADP-glucose
and G1P. The dominant ion in the spectrum is consistent with the presence of M1P (m/z 421.0749 observed with
421.0752 expected for [M-H]-). The next most abundant ion is consistent with the presence of the co-product, ADP
(m/z 426.0218 observed with 426.0221 expected for [M-H]-). (D) The dependence ofM. tuberculosisGlgA activity
on ADP-glucose. GlgA activity was determined spectrophotometrically by monitoring the production of ADP. A
representative triplicate dataset with 1 mMG1P is shown as means and SEM. The data conform to the Michaelis-
Menten eq 1 (fit shown as the solid line giving r2 = 0.82). (E) The dependence ofM. tuberculosisGlgA activity on
G1P. GlgA activity was determined spectrophotometrically by monitoring the production of ADP. A representative
triplicate dataset with 0.1 mM ADP-glucose is shown as means and SEM. Significant inhibition by G1P at
concentrations >1 mM is apparent and the dataset conforms to a simple substrate inhibition eq 2 (fit shown as the
solid line giving r2 = 0.99). (F)M. tuberculosisGlgA (Rv1212c) was heterologously expressed in theM. smegmatis
ΔtreS(u) ΔglgA(u) c-glgE-tet-off mutant. Cells were cultivated for 24 h with or without 1 μg ml-1 ATc as indicated,
and hot water extracts from 1 ml culture aliquots (normalized to OD600 nm = 0.5) were analyzed by TLC. Conditional
silencing of the glgE gene results in M1P accumulation, demonstrating thatM. tuberculosisGlgA synthesizes M1P
in vivo.
doi:10.1371/journal.ppat.1005768.g002
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of activity with glucose and glucose 6-phosphate emphasizes the importance of the phosphoryl
group at the anomeric position in the specificity of the enzyme towards its preferred acceptor
substrate, G1P. Interestingly, the enzyme also used UDP-glucose as a donor with G1P. How-
ever, it was less efficient than with ADP-glucose because the kcat was ~ten-fold lower and the
Km for UDP-glucose was ~25-fold higher (with 1 mM G1P) giving a kcat/Km ~250-fold lower.
Surprisingly, UDP-glucose was not used as a donor when glycogen was used as the acceptor, as
reported earlier [25], further restricting the ability of the enzyme to generate glycogen.
The kinetics of the formation of M1P by GlgA with ADP-glucose and G1P were then stud-
ied using the spectrophotometric assay. Most importantly, the values of kcat were up to three
orders of magnitude higher than for the glycogens. In addition, the values of Km were1 mM,
which is typical for carbohydrate substrates of enzymes. GlgA activity as a function of ADP-
glucose conformed to the Michaelis-Menten eq 1 at all concentration of G1P tested (Fig 2D
and Table 2). GlgA activity was inhibited at high G1P concentrations (Fig 2E), which con-
formed to a substrate inhibition model defined by eq 2. Control experiments showed that this
phenomenon was not due to an artefact from inadequate pH buffering capacity or limiting
Mg2+ ions because the values of Km and Ki were independent of buffer ion and Mg
2+ concen-
trations. Interestingly, kcat was nevertheless stimulated by Mg
2+. The free Mg2+ concentration
in the cytosol of Escherichia coli has been determined to be between 1 and 2 mM [32], so the
values of kcat shown in Table 2 with 5 mMMg
2+ would reasonably reflect those in vivo. Within
error, the Km and Ki for glucose 1-phosphate were very similar (~1 mM) and independent of
the ADP-glucose concentration. This is consistent with the catalytic and inhibitory binding
sites for G1P being one and the same. With a rising fixed G1P concentration, the Km of ADP-
glucose decreased while the Vmax increased before it decreased. The former is consistent with
the binding of G1P promoting the affinity of the enzyme for ADP-glucose in a ternary com-
plex. The latter again shows substrate inhibition occurring with G1P at high concentrations.
All of these properties are defining features of a compulsory-order ternary-complex mecha-
nism whereby ADP-glucose binds to the enzyme before glucose 1-phosphate [33]. In such
cases, substrate inhibition would be expected to occur when glucose 1-phosphate binds to the
enzyme before the ADP co-product is released in the final step of the catalytic cycle, leading to
the formation of a non-productive complex. Substrate inhibition by glycogen is presumably
not observed at the concentrations tested because it is a poor substrate that does not bind suffi-
ciently before ADP dissociates from the enzyme in the last step of the normal catalytic cycle.
In order to prove thatM. tuberculosis GlgA (Rv1212c) also produces M1P in vivo, we heter-
ologously expressed its gene in theM. smegmatis ΔtreS(u) ΔglgA(u) c-glgE-tet-off mutant
Table 2. Dependence of GlgA activity on ADP-glucose and G1P. Kinetic constants ± SE for GlgA with ADP-glucose and G1P were determined in tripli-
cate using the spectrophotometric assay monitoring the production of ADP. Data where ADP-glucose and G1P concentrations were varied were fitted to the
Michaelis-Menten equation either without or with substrate inhibition, respectively.
Fixed [Substrate] (mM) kcat (s-1) Km (mM) Ki (mM) Vmax (U mg-1)
glucose 1-phosphate ADP-glucose
0.25 20.0 ± 0.6 0.145 ± 0.020 27.7 ± 0.8
1.0 29.2 ± 1.3 0.121 ± 0.025 40.5 ± 1.8
2.5 19.8 ± 0.4 0.063 ± 0.006 27.5 ± 0.6
4.0 15.4 ± 0.3 0.046 ± 0.004 21.4 ± 0.4
ADP-glucose glucose 1-phosphate
0.1 39.0 ± 6.8 0.816 ± 0.204 1.450 ± 0.400 54.2 ± 9.4
0.5 97.9 ± 24.6 1.290 ± 0.400 0.578 ± 0.185 136.0 ± 34.0
4.0 80.6 ± 3.7 0.695 ± 0.045 0.895 ± 0.060 113.0 ± 6.0
doi:10.1371/journal.ppat.1005768.t002
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under control of the constitutive HSP60 promoter. While no M1P is formed in this conditional
mutant upon silencing of the glgE gene, heterologous expression ofM. tuberculosis glgA
restored M1P accumulation (Fig 2F). This demonstrates that GlgA fromM. smegmatis andM.
tuberculosis are functionally equivalent and thatM. tuberculosis GlgA is capable of synthesizing
M1P in vivo while likely producing little or no classical glycogen.
Compensatory flux of ADP-glucose links the GlgC-GlgA and TreS-Pep2
routes to M1P and α-glucan production
Our observations on the function of GlgA imply that mycobacteria make little or no glycogen
via the classical biosynthesis route, while suggesting a central role of GlgE for α-glucan produc-
tion in mycobacteria. In order to assess to what extent the two alternative M1P pathways con-
tribute to α-glucan biosynthesis, we analyzed different mutant strains of the model organismM.
smegmatis. One advantage of this species is that deletion of the glgB gene is not lethal. This is
because, unless trehalose is present in the growth medium, M1P does not build up to levels that
are toxic, in contrast toM. tuberculosis [16]. The absence of the branching enzyme GlgB leads to
the formation of very long insoluble linear α-glucans, which can be readily visualized using
iodine vapor yielding dark blue inclusion complexes [34]. Mass spectrometry of cell free crude
extracts showed small amounts of malto-oligosaccharides also accumulated in the mutant
strain. These oligomers comprised 3–18 glucose rings, too short to stain blue with iodine. Never-
theless, the majority of the α-glucan was polymeric. We then deleted glgB in variousM. smegma-
tis genetic backgrounds and stained mutant cells grown on agar plates (Fig 3A). Inactivation of
GlgC led to a strong reduction in glucan content, while the lack of TreS had only a small effect,
indicating that the GlgC-GlgA pathway is the dominant route of M1P synthesis inM. smegmatis
under the conditions tested. Combined inactivation of both GlgC and TreS resulted in, what
appeared to be, a complete absence of α-glucan. In stark contrast to the profound impact of los-
ing GlgC, it was striking that the loss of GlgA had no discernible effect on α-glucan content.
However, while mutation in either treS or glgA had only a small influence on glucan production,
their simultaneous inactivation in a ΔglgB strain completely blocked α-glucan production. This
is consistent with the existence of the two routes for M1P synthesis that diverge after GlgC.
M. tuberculosisGlgA is able to use both ADP-glucose and UDP-glucose as donors in the syn-
thesis of M1P. The ability to use these two nucleotide sugar diphosphates is a recurring theme in
trehalose and α-glucan metabolism inM. tuberculosis, because trehalose 6-phosphate synthase
OtsA also uses both [25]. Since OtsA is involved in the biosynthesis of trehalose as a substrate
for the TreS-Pep2 pathway [18], we speculated that a compensatory rechanneling of ADP-glu-
cose and/or UDP-glucose between OtsA and GlgA occurs. We therefore analyzed extracts
obtained from theM. smegmatis ΔglgA and ΔotsA single and ΔglgA(u) ΔotsA double mutants
for the presence of nucleotide sugar diphosphates by 1H NMR spectroscopy. While the accumu-
lation of ADP-glucose, and likely some UDP-glucose, was detected in theM. smegmatis ΔglgA
(u) ΔotsA double mutant, none was detected in the single mutants (Fig 3B). These findings are
consistent with the flux of ADP-glucose being redirected through OtsA when GlgA is inactive.
This likely leads to an enhanced generation of trehalose and subsequent conversion to M1P via
the TreS-Pep2 pathway, explaining why a lack of GlgA alone has little effect on glucan content.
Accumulation of ADP-glucose further implies that, apart from GlgA and OtsA, no other
enzymes significantly consume this nucleotide sugar diphosphate inM. smegmatis.
Semiquantitative dot blot analyses of cellular and capsular glucan preparations from mutant
cells using a glucan-specific monoclonal antibody corroborated the dominant role of GlgC
over TreS for glucan production inM. smegmatis. Moreover, this revealed that mutations had a
similar impact on both cytosolic and capsular glucan content, with combined inactivation of
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GlgC and TreS necessary to completely block biosynthesis of both polymers (S3B Fig). The
equivalent impact on both cytosolic and capsular α-glucans implies synthesis occurs intracellu-
larly with some of the polymer being exported to the capsule.
The GlgE pathway mediates both intracellular and capsular α-glucan
production inM. tuberculosis
The observations described so far showed that α-glucan production inM. smegmatis relies
on the GlgE pathway, and that the M1P substrate can be provided by two alternative routes,
Fig 3. Compensatory flux of ADP-glucose through GlgA and OtsA links the GlgC-GlgA and TreS-Pep2
routes for α-glucan production. (A) α-Glucan visualization inM. smegmatismutant strains. Cells were
cultivated on Middlebrook 7H10 agar plates for 3 days and exposed to iodine vapor for staining of α-glucans.
Branched α-glucans give a pale red-brown color. In the absence of branching enzyme GlgB, long linear
glucans are produced resulting in a dark blue color of cells with the intensity of staining correlating with the
amount of total cellular α-glucans. (B) Analysis of nucleotide sugar diphosphates in cell extracts ofM.
smegmatismutant strains. Cells were cultivated for 24 h in Middlebrook 7H9 liquid medium. Due to trehalose
auxotrophy of theM. smegmatis ΔglgA(u) ΔotsAmutant, 50 μM trehalose was added to all cultures. Cell
suspensions were normalized to OD600 nm, washed with PBS, concentrated 50-fold and disrupted by bead
beating. Cell-free extracts were heat inactivated for 15 min at 100°C, and 1H NMR spectroscopy was used to
detect the anomeric protons of ADP-glucose.
doi:10.1371/journal.ppat.1005768.g003
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with the GlgC-GlgA branch being dominant in this organism under the tested growth
conditions.
In order to determine the individual contribution of the GlgC-GlgA and TreS-Pep2
branches of the GlgE pathway and of the Rv3032 pathway for α-glucan production inM. tuber-
culosis, we investigated a set ofM. tuberculosismutant strains and quantified intracellular and
capsular α-glucans employing an enzymatic assay and/or by ELISA using a glucan-specific
monoclonal antibody. In contrast toM. smegmatis, inactivation of GlgC resulted in only a
moderate reduction of the intracellular and capsular glucan content, consistent with previous
studies [10], while a lack of TreS had a profound impact (Fig 4A and 4B and S3B Fig). This
indicates that under the tested culture conditions the TreS-Pep2 branch provides most of the
M1P for the GlgE pathway inM. tuberculosis whereas the GlgC-GlgA branch is much less
active. In fact, we could not detect M1P in theM. tuberculosis ΔtreS(u) ΔglgEmutant using 1H
Fig 4. The central importance of the GlgE pathway in intracellular and capsular α-glucan synthesis in
M. tuberculosis.Quantification of intracellular (A) or extracellular (i.e. capsular) (B) α-glucan inM.
tuberculosis H37Rv mutant strains. Cells were grown in Middlebrook 7H9 liquid medium for 7 days with
shaking. Intracellular glucans were measured in hot water extracts of washed cells. Capsular glucans were
measured from cell-free culture supernatants. Intracellular and capsular glucans were assayed by sandwich
ELISA employing an α-glucan specific monoclonal antibody. Similar results for intracellular glucan content
were also obtained using an enzymatic assay with cells from independent biological replicates (S3 Fig).
Values were normalized based on OD 600 nm of cultures. Values in (A) and (B) represent means of
triplicates ± SEM. (C) Visualization of the α-glucan capsule in theM. tuberculosisWT and the ΔglgC(u) ΔtreS
mutant by immunogold labelling. Cells were grown in liquid medium without shaking, fixed, labelled with an α-
glucan specific monoclonal antibody, and analyzed by electron microscopy (scale bar 0.5 μm). (D)
Quantitative evaluation of α-glucan capsule visualization as shown in (C), plotted as anti-α-glucan specific
gold particles per cell. Values represent means ± SEM (WT n = 27, ΔglgC(u) ΔtreS n = 28). Negative controls
were not treated with the primary anti-α-glucan antibody (n = 32).
doi:10.1371/journal.ppat.1005768.g004
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NMR spectroscopy. Whole genome resequencing confirmed that this strain did not harbor any
mutation in glgC or glgA that might block the alternative route to M1P, so any amount of M1P
produced was below the limit of detection. As withM. smegmatis, inactivation of GlgA had a
smaller influence on α-glucan levels compared to GlgC, suggesting that compensatory rechan-
neling of ADP-glucose between GlgA and OtsA might also occur inM. tuberculosis. However,
in contrast toM. smegmatis, we were unable to generate theM. tuberculosis ΔglgA(u) ΔotsA
double mutant despite repeated attempts, implying that combined inactivation is lethal, poten-
tially due to accumulation of toxic levels of ADP-glucose. As withM. smegmatis, combined
inactivation of either GlgC and TreS or GlgA and TreS resulted in mutants that were virtually
devoid of α-glucans (Fig 4A and 4B and S3B Fig). The equivalent impact on both cytosolic and
capsular α-glucans again implies synthesis occurs intracellularly with some of the polymer
being exported to the capsule. Importantly, deletion of both treS and glgE also blocked the pro-
duction of α-glucan, despite the presence of intact glgC and glgA genes. This emphasizes the
fundamental importance of the GlgE pathway for the biosynthesis of both intracellular and
capsular α-glucans inM. tuberculosis and is consistent with GlgA having no direct role in poly-
mer synthesis (Fig 4A and 4B). To corroborate the requirement of the GlgE pathway for extra-
cellular α-glucans, we analyzed cells by immunogold electron microscopy, proving that theM.
tuberculosis ΔglgC(u) ΔtreSmutant completely lacked capsular α-glucans (Fig 4C and 4D).
Rv3032 has previously been implicated in the formation of intracellular, but not capsular,
α-glucan [10]. However, in contrast to the dominant role of the GlgE pathway, in our hands
deletion of Rv3032 had no significant impact on the levels of either intracellular or capsular α-
glucans regardless of the genetic backgrounds tested (Fig 4A and 4B and S3B Fig). In addition,
the presence of Rv3032 did not rescue any of the α-glucan-deficient strains. Furthermore, the
dispensability of Rv3032 for α-glucan formation inM. tuberculosis was supported by the find-
ing that theM. tuberculosis ΔglgC(u) ΔotsAmutant displayed trehalose auxotrophy (S4 Fig). In
the absence of OtsA, mycobacteria can produce trehalose only from internal α-glucans via the
TreX-TreY-TreZ pathway [18], implying that theM. tuberculosis ΔglgC(u) ΔotsAmutant is
essentially free of α-glucans, despite Rv3032 being present. Furthermore, while Sambou et al.
[10] postulated that combined inactivation of Rv3032 and GlgA is lethal, anM. tuberculosis
ΔglgA(u) ΔRv3032 double mutant was viable in our hands and exhibited only a slight reduction
in α-glucan content (S3B Fig). These findings strongly suggest that Rv3032 has little or no role
in the synthesis of α-glucan.
α-Glucan biosynthesis via the GlgE pathway is important for virulence of
M. tuberculosis in mice
Sambou and colleagues have reported that a glgAmutant was impaired in its ability to persist
in mice and linked this to a somewhat lower level of capsular α-glucan [10]. However, the full
extent to which α-glucan is important for the virulence ofM. tuberculosis remained unclear
because they were unable to generate an α-glucan-deficient strain. Having now elucidated the
configuration of pathways underlying α-glucan biosynthesis, it was possible, for the first time,
to test the full impact of α-glucan onM. tuberculosis pathogenesis in mice employing rationally
designed α-glucan-deficient mutants. TheM. tuberculosis ΔglgC(u) ΔtreSmutant was signifi-
cantly attenuated for growth in the lung and spleen of BALB/c mice during both the acute and
chronic phase of infection (Fig 5). This is in large agreement with the phenotype reported for
the glgAmutant but differs in that this single mutant was specifically attenuated only during
the chronic infection phase [10]. Genome sequencing confirmed the genotype of the double
mutant strain and a lack of secondary mutations, providing unequivocal evidence that α-glu-
can is indeed required for the full virulence of the wild-type strain. Interestingly, deletion of
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treS alone had no effect in a mouse model (Fig 5). This implies that while the TreS/Pep2-de-
pendent route for M1P synthesis dominates inM. tuberculosis in culture, the pathways are sub-
ject to regulation [25, 35] such that the GlgA-dependent route is more important during
infection consistent with previous work [10]. However, only combined inactivation of both
M1P-synthesis routes can effectively block glucan formation throughout infection.
Discussion
Prior to this study, it was thought that three partially redundant routes collectively contribute
to α-glucan production inM. tuberculosis and other mycobacteria: the GlgC-GlgA pathway for
classical glycogen, the recently discovered TreS-Pep2-GlgE pathway for trehalose-to-glucan
conversion, and the Rv3032 pathway. This multiplicity of pathways for the production of one
type of molecule was puzzling, so it was unclear how these pathways interrelate in the biosyn-
thesis of intracellular and capsular α-glucans. Refuting previous assumptions, we have now
demonstrated that both cytosolic and capsular α-glucan polymers inM. tuberculosis,M. smeg-
matis and probably all other mycobacteria are predominantly, if not exclusively, synthesized by
the maltosyltransferase GlgE together with the branching enzyme GlgB. In addition, the acti-
vated M1P donor substrate of GlgE is unexpectedly generated by two alternative routes: TreS--
Pep2 as described previously [16] and GlgC-GlgA (Fig 6). These findings on the central role of
the GlgE pathway in global glucan production in mycobacteria support our very recent obser-
vation that purified recombinant GlgE and GlgB together, using M1P as the sole substrate, are
sufficient to generate α-glucans in vitro possessing the same distinctive structural features as
the polymers isolated from the cytosol and capsule ofM. tuberculosis [13].
While mycobacterial GlgA was believed to be a glycogen synthase, we have shown that
GlgA fromM. tuberculosis is a M1P-producing glucosyltransferase three orders of magnitude
more efficient at transferring glucose from ADP-glucose to glucose 1-phosphate than to glyco-
gen. By comparing the rates of reaction with a series of potential acceptors, it is apparent that
maltooligosaccharides are even poorer substrates than glycogen, highlighting that the +2 sub-
site of GlgA has a clear preference for an α-1-phosphate group. It would therefore be more
appropriate to define the enzyme as an ADP-α-D-glucose:α-D-glucose-1-phosphate 4-α-D-
glucosyltransferase (EC 2.4.1). Furthermore, since mycobacterial GlgA likely produces little or
no classical glycogen in vivo, the name GlgA appears no longer to be biologically relevant and
we propose to call the enzymes with this new activity GlgM in future publications.
Fig 5. Importance of GlgE-mediated α-glucan synthesis for virulence ofM. tuberculosis in mice.
BALB/c mice were challenged by intravenous infections with 5 × 104 colony forming units ofM. tuberculosis
α-glucan mutant strains (mean ± SD, n = 3 per time point). The growth of the double mutant was significantly
attenuated in lung and spleen as compared to wild-type at all time-points (p < 0.05), except for the earliest 21
days post-infection time point in the lung.
doi:10.1371/journal.ppat.1005768.g005
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GlgA fromM. tuberculosis is a GT4 family enzyme according to the CAZy database [36]
(http://www.cazy.org/) and is predicted to have a GT-B fold and be a retaining enzyme. We
have now confirmed that it is an α-retaining enzyme. Such glycosyltransferases are thought to
use an SNi-type catalytic mechanism [37]. Indeed, it has recently been reported that trehalose
6-phosphate synthase OtsA, a UDP-glucose:D-glucose-6-phosphate 1-α-D-glucosyltransferase
(EC 2.4.1.15) and member of the GT20 family, uses an SNimechanism and kinetic and struc-
tural evidence supports the compulsory binding of UDP-glucose before glucose 6-phosphate
[38, 39]. It seems likely that GlgA fromM. tuberculosis shares these properties because it is pre-
dicted to also have a GT-B fold, catalyzes the same underlying chemistry and uses a compul-
sory-order ternary-complex mechanism. Interestingly, substrate inhibition of GlgA could help
limit accumulation of M1P when G1P levels were high. Importantly, experimentally character-
ized and, to the best of our knowledge, bone fide glycogen synthases [26] also share a GT-B fold
and are classified as either GT3 or GT5 family enzymes depending on whether they come from
eukaryotes or prokaryotes, respectively [36]. All GT5 family enzymes characterized to date are
Fig 6. Revised model of GlgE-mediated intracellular and capsular α-glucan synthesis in
mycobacteria. The M1P building block for the maltosyltransferase GlgE is formed via two alternative routes,
TreS-Pep2 and GlgC-GlgA. Both routes are connected via the shared use of ADP-glucose by GlgA and OtsA,
the latter providing the trehalose substrate for the TreS-Pep2 pathway. GlgA, like OtsA, is also capable of
using UDP-glucose as a donor, which in turn is produced from G1P by GalU, but this appears to be less
significant in vivo. GlgE is essential for intracellular and capsular α-glucan synthesis and generates linear
maltooligosaccharides as the substrates for the branching enzyme GlgB. α-Glucans are produced
intracellularly with partial coupling to secretion by unknown transport mechanisms. Steps highlighted in red
are new findings as described in this report. G6P, glucose 6-phosphate; G1P, glucose 1-phosphate; M1P, α-
maltose 1-phosphate; T6P, trehalose 6-phosphate; ADPG, ADP-glucose; UDPG, UDP-glucose.
doi:10.1371/journal.ppat.1005768.g006
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glycogen synthases. This contrasts with the GT4 family membership ofM. tuberculosis GlgA.
We extended our recent bioinformatic analysis [40] and identified that GT4 and GT5 family
membership of apparent glycogen synthase homologues can be a feature of bacteria whether
they are either Gram positive or negative and whether the glgA gene coexists with glgE in a
given genome or not in all combinations with one exception. It is striking that in every case
where these two genes coexist in Gram positive bacteria, the GlgA belongs exclusively to the
GT4 family and never to the GT5 family. The coexistence of the genes is consistent with the
new activity being associated with the alternative route for the generation of M1P for the GlgE
pathway in this clade. These bacteria are typically actinomycetes including mycobacteria and
streptomycetes. Overall, ~32% of the GlgA homologues are GT4 members, implying that the
proportion of microbes that possess the classical glycogen pathway is ~20%, a value lower than
previously estimated [40].
The two alternative pathways for generating the M1P building block for GlgE-mediated α-
glucan production in mycobacteria, TreS-Pep2 and GlgC-GlgA, are linked via the shared use
of the intermediate ADP-glucose by GlgA and OtsA (Fig 6). GlgA and OtsA can also use UDP-
glucose as donors in vitro in the synthesis of M1P or trehalose 6-phosphate, respectively [25].
However, the phenotypes of mutant strains suggest that ADP-glucose is the main donor in vivo
under the used growth conditions because little, if any, UDP-glucose accumulated in theM.
smegmatis ΔglgA(u) ΔotsA double mutant. UDP-glucose might instead be primarily used for
production of arabinogalactan, via the essential UDP-galactose 4´-epimerase GalE1
(MSMEG_6142, homologue of Rv3634c inM. tuberculosisH37Rv), which converts UDP-glu-
cose to UDP-galactose. In any case, such donor promiscuity might provide metabolic plasticity
and the opportunity for additional levels of regulation. The flux of ADP-glucose seems to be
sufficiently redirected such that the net rate of M1P generation and α-glucan accumulation can
be balanced to some extent when one of the two routes is perturbed. However, the two routes
are obviously subject to regulation such that the TreS-Pep2 pathway dominates inM. tubercu-
losis in culture while the GlgA-dependent route is more important during infection. The
molecular basis underlying these regulatory mechanisms under different physiological condi-
tions remains to be fully elucidated.
Our data show that the Rv3032 pathway does not contribute substantially, if at all, to α-glucan
production in mycobacteria under the tested culture conditions. Rather, its function appears to
be restricted to the synthesis of specialized oligomeric α-glucan derivatives such as MGLPs [15].
This contrasts with another report claiming that an Rv3032 gene deletion mutant ofM. tubercu-
losis exhibited a somewhat reduced intracellular, but not capsular, glucan content [10]. This
might be due to use of different culture conditions or strains used. Although our data cannot rule
out that Rv3032 uses ADP-glucose and/or UDP-glucose to some extent for the synthesis of gly-
cogen-like α-glucans under certain circumstances, this seems unlikely in light of our findings.
Nevertheless, given the new specificity ofM. tuberculosisGlgA, we can almost certainly rule out a
previously proposed functional redundancy betweenM. tuberculosisGlgA and Rv3032. In fact,
we could successfully generate anM. tuberculosis ΔglgA(u) ΔRv3032 double mutant, clearly refut-
ing the hypothesized synthetic lethality between GlgA and Rv3032 [10]. In addition, theM.
tuberculosis ΔglgA(u) ΔRv3032 double mutant still produced α-glucan in culture.
Our study demonstrates that the GlgE pathway produces both intracellular and capsular α-
glucans inM. tuberculosis, although separate biosynthetic routes had previously been postu-
lated [10]. This implies that capsular α-glucans have an intracellular biosynthetic origin that
necessitates the presence of dedicated transporters for α-glucan secretion, which have yet to be
identified. Indeed, our model is in accord with the observation that the cytosolic and capsular
materials fromMycobacterium bovis [12] andM. tuberculosis [13] have very similar physico-
chemical properties, consistent with a common biosynthetic origin.
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A previous report that anM. tuberculosis glgAmutant was impaired in virulence [10] must
now be reinterpreted as a block in the production of the donor substrate of GlgE rather than in
the formation of the polymer. Furthermore, our new understanding of the metabolic network
has established why blocking GlgA alone cannot completely prevent polymer synthesis,
because the TreS-Pep2 route can compensate in the supply of M1P for GlgE. It was therefore
necessary to generate double mutants to create the first strains devoid of α-glucan. This was
achievable with several combinations of genes in a rational way. Importantly, we have demon-
strated that such anM. tuberculosis strain devoid of α-glucan is less virulent than the wild-type
providing the first evidence directly linking the GlgE pathway with virulence.
This work provides the first complete understanding of the metabolic network associated
with formation of α-glucan in mycobacteria. This has implications for the development of new
therapies. GlgE is a genetically validated target [16, 41] that has already attracted attention
[42]. Blocking GlgE leads to the toxic accumulation of M1P [16], so potential suppressor muta-
tions in four genes (treS, pep2, glgC, glgA) associated with M1P formation could potentially res-
cue growth and limit the in vivo efficacy of GlgE inhibitors. However, the continued absence of
α-glucan production in such suppressor mutants would still compromise the virulence of the
pathogen, making GlgE an even more attractive target. The targeting of other enzymes in the
pathways to block the production of α-glucan can now be done in a more rational manner.
Similarly, the feeding of substrate analogues in labelling studies can be done in a more predict-
able way. Mutant strains blocked in individual pathways and/or devoid of α-glucan will also be
a useful resource for future studies. Furthermore, attenuatedM. tuberculosis strains that lack α-
glucan could be better suited as a vaccine because not only might they be less able to evade
immunity but other antigenic cell surface components might also be physically more exposed.
Materials and Methods
Strains and growth conditions
All strains were derived fromM. smegmatismc2155 andM. tuberculosisH37Rv and are listed
in S1 and S2 Tables. Cells were grown aerobically at 37°C in Middlebrook 7H9 media supple-
mented with 0.5% (v/v) glycerol and 0.05% (v/v) Tyloxapol and containing 10% (v/v) ADS
enrichment (5%, w/v, bovine serum albumin fraction V (BSA); 2%, w/v, glucose; 0.85%, w/v,
sodium chloride). Hygromycin (50 mg l-1), kanamycin (20 mg l-1) and apramycin (10 mg l-1)
were added for selection of appropriate strains.
Generation of site-specific gene deletion mutants
Site-specific gene deletion mutants ofM. smegmatismc2155 andM. tuberculosisH37Rv were
generated by specialized transduction employing temperature-sensitive mycobacteriophages
essentially as described previously [43]. Briefly, for the generation of allelic exchange constructs
for gene replacement with a γδres-sacB-hyg-γδres cassette comprising a sacB as well as a hygro-
mycin resistance gene flanked by res-sites of the γδ-resolvase, upstream- and downstream-
flanking DNA regions were amplified by PCR employing the oligonucleotides listed in S3
Table. Subsequently, the upstream and downstream flanks were digested with the indicated
restriction enzymes, and ligated with Van91I-digested p0004S vector arms (= pYUB1471 [44]).
The resulting knock-out plasmids were then linearized with PacI and cloned and packaged
into the temperature-sensitive phage phAE159 [44], yielding knock-out phages which were
propagated inM. smegmatis at 30°C. Allelic exchange inM. smegmatis andM. tuberculosis
using the knock-out phages was achieved by specialized transduction using hygromycin (50
mg l-1) for selection, resulting in gene deletion and replacement by the γδres-sacB-hyg-γδres
cassette. For the generation of unmarked mutants, the γδres-sacB-hyg-γδres cassette was
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removed employing specialized transduction using the phage phAE280 expressing the γδ-
resolvase [44] using sucrose (3%, w/v) for counterselection. All mutants were verified by South-
ern analysis of digested genomic DNA using appropriate restriction enzymes and probes. For
the unmarked Rv1212c locus, an additional diagnostic PCR was performed employing primers
binding outside the flanks used for allelic exchange, and the PCR product was sequenced con-
firming the correct genotype of theM. tuberculosis ΔglgA(u) and ΔglgA(u) ΔRv3032 mutants.
Furthermore, whole genome sequencing was carried out for theM. tuberculosis ΔglgC(u) ΔtreS
and ΔtreS(u) ΔglgEmutants to confirm their genotypes.
Generation of the conditionalM. smegmatis c-glgE-tet-off mutant
For establishing regulated expression of the glgE gene, a synthetic gene cassette (hyg-Pmyc1-
4XtetO) comprising a hygromycin resistance gene and the Pmyc1 promoter fromM. smegmatis
engineered to contain four tetO operator sites, which are the DNA binding sites for the cognate
repressor protein TetR, was inserted immediately upstream of the glgE start codon inM. smeg-
matis. Targeted gene knock-in was achieved by specialized transduction employing tempera-
ture-sensitive mycobacteriophages essentially as described above for gene deletion mutants.
Briefly, for the generation of allelic exchange constructs for site-specific insertion inM. smegma-
tis of the hyg-Pmyc1-4XtetO cassette, upstream- and downstream DNA regions flanking the
glgE start codon were amplified by PCR employing the oligonucleotides listed in S3 Table. Sub-
sequently, the upstream and downstream flanks were digested with the indicated restriction
enzymes, and ligated with Van91I-digested pcRv1327c-4XtetO vector arms (sequence provided
in S1 Text). The resulting knock-in plasmid was then linearized with PacI and cloned and pack-
aged into the temperature-sensitive phage phAE159 [44], yielding a knock-in phage which was
propagated inM. smegmatis at 30°C. Allelic exchange inM. smegmatis using the knock-in
phage at the nonpermissive temperature of 37°C was achieved by specialized transduction using
hygromycin (50 mg l-1) for selection, resulting in site-specific insertion of the hyg-Pmyc1-
4XtetO cassette. TheM. smegmatis c-glgE-4XtetO knock-in mutant was verified by Southern
analysis of digested genomic DNA using an appropriate restriction enzyme and probe. For
achieving controlled gene expression of the target gene glgE, a synthetic gene (revtetR) derived
from Tn10 tetR encoding a mutated TetR protein with reversed binding affinity to tetO sites
upon binding of tetracycline [45] was heterologously expressed in the knock-in mutant. For
this, the revtetR gene was amplified by PCR employing the oligonucleotide primer pair 5
´-TTTTTGAATTCATGAGCACGATCCGCGGTACCATC-3´ and 5´-TTTTTAAGCTT
AGGAGCCGCTCTCGCACTTCAG-3´ using the plasmid pTC-28S15-0X (Addgene plasmid
20316) as a template and cloned using the restriction enzymes EcoRI andHindIII (underlined)
into the episomal E. coli-mycobacterium shuttle plasmid pMV261-RBS-G, which is a derivative
of plasmid pMV261 [46] harboring a mutated ribosome binding site (sequence provided in S2
Text). The resulting plasmid pMV261::revtetR_RBS-G providing constitutive gene expression
from the HSP60 promoter in mycobacteria was transformed by electroporation into theM.
smegmatis c-glgE-4XtetO knock-in mutant using solid medium containing 50 mg l-1 hygromy-
cin and 20 mg l-1 kanamycin for selection. This yielded the conditional mutantM. smegmatis c-
glgE-4XtetO pMV261::revtetR_RBS-G (referred to asM. smegmatis c-glgE-tet-off mutant) allow-
ing silencing of the glgE gene in presence of anhydrotetracycline (ATc).
Genetic complementation ofM. smegmatismutants
TheM. tuberculosis glgC gene was amplified by PCR employing the oligonucleotide primer
pair 5´-TTTTTCAGCTGCAATGAGAGAAGTGCCGCACGTGCTG-3´ and 5
´-TTTTTAAGCTTCTAGATCCAAACACCCTTGCCCAC-3´ using genomic DNA as a
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template and cloned using the restriction enzymes PvuI andHindIII (underlined) into the inte-
grative E. coli-mycobacterium shuttle plasmid pMV361(Kan) [46]. The resulting plasmid
pMV361::Rv1213, providing constitutive gene expression from the HSP60 promoter in myco-
bacteria, was introduced by electroporation into theM. smegmatis ΔglgE(u) Δpep2 glgC:IS1096
mutant using solid medium containing 50 mg l-1 hygromycin and 20 mg l-1 kanamycin for
selection. TheM. tuberculosis glgA gene was amplified by PCR employing the oligonucleotide
primer pair 5´-TTTTTTTAATTAAATGCGGGTGGCGATGTTGACTCG-3´ and 5
´-TTTTTAAGCTTTTACGCGCACACCTTCCGGTAGATG-3´ using genomic DNA as a
template and cloned using the restriction enzymes PacI and HindIII (underlined) into the inte-
grative E. coli-mycobacterium shuttle plasmid pMV361(Apra)-PacI, which is a derivative of
plasmid pMV361 [46] harboring a PacI cloning site. The resulting plasmid pMV361(Apra)::
Rv1212c providing constitutive gene expression from the HSP60 promoter in mycobacteria as
well as the empty vector control were introduced by electroporation into the conditionalM.
smegmatis ΔtreS(u) ΔglgA(u) c-glgE-tet-off mutant using solid medium containing 50 mg l-1
hygromycin, 20 mg l-1 kanamycin, and 10 mg l-1 apramycin for selection.
Genome sequencing
Genomes were sequenced using an Illumina HiSeq 2500 next-generation sequencer (San
Diego, CA, USA) and compared with the parentM. tuberculosisH37RvMA genome (GenBank
accession GCA_000751615.1) [47]. Genomic DNA was extracted from bacterial cultures and
prepared for sequencing using the standard paired-end genomic DNA sample prep kit from
Illumina. Paired-end sequence data was collected with a read length of 106 bp. Base-calling was
performed using Casava software, v1.8. The reads were assembled using a comparative genome
assembly method. The mean depth of coverage was 188× (ΔglgC(u) ΔtreS) and 246× (ΔtreS(u)
ΔglgE).
The deletion of the appropriate genes in the ΔglgC(u) ΔtreS and ΔtreS(u) ΔglgEmutants was
confirmed. The only additional difference in the ΔglgC(u) ΔtreSmutant was a single polymor-
phism giving rise to a synonymous silent mutation (L190L) in Rv2217 (lipB). The decreased
virulence of this strain (Fig 5) is therefore clearly attributable to the loss the glgC and treS
genes. The ΔtreS(u) ΔglgEmutant had four additional mutations that appear unrelated to α-
glucan metabolism. Rv1219c is a transcription factor whose regulon is currently unknown.
There was a loss of CC 28 bp upstream (5') of this gene. Rv1739c is a sulfate ABC transporter
in which there was a V524I mutation. Rv2402 is annotated as a hypothetical protein and there
was a H621D mutation. PpsE is a component of the type I (modular) polyketide synthase
involved in producing phenolphthiocerol dimycolate, a cell-wall glycolipid. There was a muta-
tion giving rise to a loss of amino acid A567. It is not uncommon for random secondary muta-
tions like these to occur in a genetically manipulated strain.
Carbohydrate TLC analysis
Carbohydrates were extracted from equal amounts of cells with hot water (95°C for 4 h) and
analyzed by TLC on Silica gel 60 (EMD Chemicals) using the solvent system 1-propanol:ethyl
acetate:water (6:1:3, v/v/v). Substances were visualized by immersing TLC plates in 10% (v/v)
sulfuric acid in ethanol followed by charring at 180°C for 10 min.
RecombinantM. tuberculosis proteins
TheM. tuberculosis glgA and glgP genes were synthesized with optimized codon usage for
expression in Escherichia coli (Genscript Corporation, Piscataway, NJ), allowing their produc-
tion with an N-terminal His6 tag and TEV cleavage site. The constructs were ligated into a
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pET21a expression vector (Novagen, Darmstadt, Germany) usingNdeI and BamHI restriction
sites. For the production of GlgA, transformed E. coli SoluBL21 cells (AMS Biotechnology
Europe Ltd) were grown at 18°C to an OD600 nm of 0.6 in Lysogeny Broth and expression was
induced with 0.5 mM isopropyl β-D-thiogalactopyranoside. Bacteria were harvested and lysed
after a further 16 h of incubation. The enzyme was purified using a 1 ml HisTrap FF column
(GE Healthcare, Amersham, United Kingdom) with an imidazole gradient followed by a Super-
dex S200 16/60 size exclusion chromatography column (Pharmacia Biotech, Amersham, United
Kingdom) with 50 mMMOPS buffer, pH 8.0, containing 0.1 mM ethylenediaminetetraacetic
acid, 5 mMMgCl2, 5% (w/v) sucrose, 10% (v/v) glycerol and 50 mMNaCl. GlgA-containing
fractions were pooled and concentrated to ~1.5 mg l-1 and aliquots were stored at -80°C.
A similar strategy was used for the production of recombinantM. tuberculosis GlgP protein
with modifications, which was produced in E. coli BL21 Star(DE3) cells (Novogen) grown at
18°C for 16 h in auto-induction medium [48] supplemented with 1% (v/v) ethanol. GlgP-con-
taining fractions from Ni-affinity chromatography were dialyzed into 50 mMHEPES buffer,
pH 7.5, and did not require further purification.
Enzyme assays
GlgA activity was measured using a continuous enzyme-coupled spectrophotometric assay
that monitors ADP release. Chemicals were purchased from Sigma Aldrich. Unless otherwise
stated, all enzyme assays were carried out at 37°C in 50 mM Bis-Tris propane (pH 7.0) contain-
ing 5 mMMgCl2, 0.3 mMNADH, 1 mM phosphoenolpyruvate, 1 U lactate dehydrogenase, 1
U pyruvate kinase and 0.2 mg ml-1 BSA. Saturations kinetics for ADP-glucose and α-glucose
1-phosphate were measured by fixing the concentration of one substrate and whilst varying the
other. The effect of pH was determined using 50 mMNa/K phosphate (pH 5.0), Bis-Tris (pH
6.0) and Bis-Tris propane (pH 7.0, 8.0 and 9.0) buffers. The dependence on pH and tempera-
ture (25–50°C) were determined using 1 mM each of ADP-glucose and glucose 1-phosphate.
The activity of GlgA was also measured with rabbit liver (Sigma) and Streptomyces venezuelae
glucan (details to be described elsewhere) as acceptors (0.3–10 mg l-1) with 1 mM ADP-glu-
cose. Enzyme concentrations were such to allow reactions to progress linearly for 5 min with
total donor consumption being< 10%. Initial rates (v0/[E]) were measured by monitoring the
oxidation of NADH at 340 nm using a Perkin Elmer Lambda 25 spectrophotometer. One unit
of enzyme activity refers to the production of 1 μmol of ADP per min. Initial rate data were fit-
ted to the Michaelis-Menten equation without (Eq 1) or with (Eq 2) substrate inhibition using
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GlgA-catalyzed reactions with 1 mM each of ADP-glucose and glucose 1-phosphate were
also monitored using 1H NMR spectroscopy. Spectra of 0.5 ml samples containing 10% v/v
D2O at 20°C were recorded on a Bruker Avance III 400 MHz spectrometer and data were ana-
lyzed using Topspin 2.1 software spectrometer (Bruker Biospin Ltd). Other potential acceptors,
including maltodextrin (dextrose equivalent 16.5–19.5; i.e. with an average DP of ~5–6), were
obtained from Sigma-Aldrich. The GlgP-catalyzed reaction was also monitored using NMR
spectroscopy and was assayed in either 30 mM phosphate buffer, pH 7.5, containing 1 mM
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pyridoxal phosphate and 30 mg ml-1 glycogen or in 50 mMHEPES, pH 7.5, containing 1 mM
pyridoxal phosphate, 10 mMG1P and 30 mg ml-1 glycogen.
Finally, the products of a GlgA-catalyzed reaction were diluted 1:100 into 50% methanol/
water with 0.1% NH4OH and infused into a Synapt G2 mass spectrometer (Waters, Manches-
ter, UK) at 5 μl min-1 using a syringe pump (Harvard Apparatus, Kent, UK). The mass spec-
trometer was controlled by Masslynx 4.1 software (Waters), operated in resolution and
negative ion mode and calibrated using sodium formate. The sample was analyzed for 2 min
with 1 s MS scan time over the range of 50–1200m/z with 2.5 kV capillary voltage, 40 V cone
voltage and 120°C cone temperature. Leu-enkephalin peptide (2 ng ml-1, Waters) was infused
at 10 μl min-1 as a lock mass and measured every 10 s. The peptide was fragmented for dual
point calibration (m/z 236.1041 and 554.262), which was applied during the acquisition. Spec-
tra were generated in Masslynx 4.1 by combining a number of scans, and peaks were centred
using the median of areas.
Glucan quantification in mycobacterial strains
Capsular α-glucans were determined in cell-free culture supernatants fromM. tuberculosis
cells grown in presence of 0.05% (v/v) tyloxapol as shaking cultures, conditions under which
capsular α-glucans are stripped off and released from the cells [6]. Cultures were harvested and
supernatants were filter-sterilized through a 0.22 μm pore size filter to remove remaining cells.
To obtain intracellular α-glucans,M. tuberculosis cells were harvested, washed twice with PBS
containing 0.05% tyloxapol to remove capsular α-glucans and media components, and subse-
quently extracted with hot water (95°C for 4 h).
Capsular and intracellular α-glucans were determined by sandwich ELISA as described pre-
viously [49]. Briefly, medium binding ELISA plates (Greiner) were coated with anti-α-glucan
monoclonal antibody (IV58B6)[50] in a final concentration of 5.0 μg ml-1 in PBS and incu-
bated overnight under gentle shaking at room temperature (RT). The plates were washed 4
times with 200 μl/well PBS containing 0.05% (v/v) Tween 20 and subsequently blocked with
200 μl/well of 1% (w/v) BSA in PBS for 1 h at RT under gentle shaking. Then, the blocking
solution was removed and 100 μl/well of α-glucan samples or rabbit liver glycogen standard
(twofold serial diluted in 1% (w/v) BSA in PBS) were added and incubated for 1.5 h at RT
under gentle shaking. After this, the plates were washed 4 times with PBS containing 0.05% (v/
v) Tween 20 before 50 μl/well of the pre-incubated secondary antibody solution (see below)
was added and incubated for 1.5 h at RT under gentle shaking. Subsequently, the plates were
washed 6 times with 200 μl/well PBS containing 0.05% (v/v) Tween 20 and developed by add-
ing 100 μl/well ortho-phenylene diamine dihydrochloride (OPD) coloring solution (10 mg
OPD; 10 ml OPD buffer (0.1 M citric acid; 0.2 M Na2HPO4; pH = 5.5); 5.0 μl 30% H2O2) for 4
min. The coloring was stopped by adding 50 μl/well 10% H2SO4, and optical density was mea-
sured at 492 nm using a plate reader.
The secondary antibody solution was made by first incubating 33.3 μl anti-α-glucan mono-
clonal antibody (1.5 mg l-1) with 10 μg goat-anti-mouse IgM (horse radish peroxidase-conju-
gate) (Life Technologies) and 56.7 μl PBS containing 0.05% (v/v) Tween 20 for 2 h at RT.
Then, 100 μl clone 20 (2.0 mg l-1) (an irrelevant mouse IgM antibody [51]) and 50 μl normal
goat serum was added and incubated for 1.5 h at RT. Finally, the pre-incubated secondary anti-
body solution was diluted in 5.25 ml PBS containing 1% (w/v) BSA.
Semiquantitative glucan dot blot analysis using the anti-α-glucan monoclonal antibody was
done essentially as described previously [49].
For enzymatic quantifications of intracellular glucans, 25 μl aliquots of hot water cell
extracts (see above) were mixed with 15 μl acetic acid (1 M), 60 μl sodium acetate (0.2 M; pH
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5.2) and 5 μl amyloglucosidase solution (1000 U ml-1 in H2O, Fluka) and incubated at 57°C for
15 h. For quantification of the liberated glucose, 10 μl of this amyloglucosidase-treated sample
was mixed with 100 μl glucose oxidase/peroxidase/o-dianisidine solution (Sigma) and incu-
bated at 37°C for 30 min. Reactions were stopped by the addition of 75 μl sulphuric acid (6 M),
and absorbance was measured at 531 nm. Controls without amyloglucosidase addition were
done to correct for the presence of free glucose in the samples. Glucan concentrations were
estimated using rabbit liver glycogen as a reference.
Immunogold labeling and electron microscopy for visualization of
capsular α-glucans
M. tuberculosisWT and the ΔglgC(u) ΔtreS double mutant were grown in Middlebrook 7H9
liquid medium supplemented with 10% (v/v) ADC enrichment (BD, Breda, The Netherlands)
and 0.05% (v/v) Tween 80 without shaking for 17 days at 37°C. Subsequently, the strains were
centrifuged at 2000×g for 10 minutes and bacterial pellets were resuspended in PBS. The bacte-
rial cells were fixed with 4% (w/v) paraformaldehyde and 0.4% (v/v) glutaraldehyde in PHEM
buffer (120 mM PIPES, 50 mMHEPES, 20 mM EGTA, 4 mMMgCl2, pH 6.9) for 4 h. Next,
the fixed cells were centrifuged at 2000×g for 10 min and carefully resuspended in storage solu-
tion (PHEM buffer containing 0.5%, w/v, paraformaldehyde). The fixed cells were spotted
(3.0 μl, cell suspensions adjusted to 0.55 OD600 nm) onto carbon coated EM grids (EMS, Hat-
field, PA, USA) and dried for 15 min at 37°C. Next, the EM grids were incubated 2 times for 2
min with 0.15% (w/v) glycine in PBS and blocked for 10 min at RT in PBS supplemented with
1% (w/v) BSA. Subsequently, the EM grids were immunolabeled for 3 h at RT using mouse
anti-α-glucan monoclonal antibody at 10 μg ml-1 [50]. The EM grids were washed 3 times for 3
min at RT in 0.1% (w/v) BSA in PBS and incubated with biotin-conjugated goat anti-mouse
IgM (0.1 μg ml-1, Zymed) secondary antibody in 1.0% (w/v) BSA in PBS for 45 min at 37°C.
Next, the EM grids were washed 3 times for 3 min in 0.1% (w/v) BSA in PBS at RT and immu-
nogold labeled with 10 nm-gold particle labeled goat anti-biotin tertiary antibody (1/20 dilu-
tion, Aurion) in 1.0% (w/v) BSA in PBS for 30 min at 37°C. Subsequently, EM-grids were
washed 5 times for 2 min in PBS and incubated with 1% (v/v) glutaraldehyde in PBS for 5 min
at RT. Finally, the EM grids were washed 6 times for 1 min with H2O, dried overnight and
stored in a grid-box for EM analysis. The EM pictures were obtained by using Electron Micro-
scope (CM100 BIOTRIM, Philips) and digital camera (Morada 9.2, Olympus) with ITEM
imaging software (version 5.2).
Animal infections
BALB/c mice (4 to 6-week-old females; US National Cancer Institute) were infected intrave-
nously through the lateral tail vein with 5 × 104 CFU of the indicated exponentially growingM.
tuberculosis strains suspended in 200 μl PBS containing 0.05% (v/v) Tween 80. At different
time points, three mice per group were killed, and bacterial burden was determined by plating
serial dilutions of lung and spleen homogenates onto Middlebrook 7H10 agar plates supple-
mented with 10% (v/v) OADC enrichment (Becton Dickinson Microbiology Systems) and
0.5% (v/v) glycerol.
Ethics statement
Mouse studies were performed in accordance to National Institutes of Health guidelines using
recommendations in the Guide for the Care and Use of Laboratory Animals. The protocols
used in this study were approved by the Institutional Animal Care and Use Committee of
Albert Einstein College of Medicine (Protocol #20120114).
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Supporting Information
S1 Fig. The configuration of metabolic pathways relating to α-glucans thought to exist in
M. tuberculosis prior to (left panel) or after (right panel) the work currently presented.
G6P, glucose 6-phosphate; G1P, glucose 1-phosphate; M1P, α-maltose 1-phosphate; T6P, tre-
halose 6-phosphate; ADPG, ADP-glucose; UDPG, UDP-glucose; MGLP, methylglucose lipo-
polysaccharide.
(TIF)
S2 Fig. GlgP is a G1P-forming glycogen phosphorylase with no involvement in M1P syn-
thesis. (A) Enzymatic activity of recombinantM. tuberculosis GlgP monitored using 1H NMR
spectroscopy. A broad signal (~5.32 ppm) is associated with the α-1,4 linkages within the gly-
cogen polymer in the absence of enzyme (upper 1H NMR spectrum). The formation of reso-
nances consistent with G1P were clearly observed (~5.36 ppm in the lower spectrum) when
GlgP was incubated with glycogen (30 mg ml-1) and inorganic phosphate (30 mM). There was
no indication of the corresponding well-defined doublet associated with formation of M1P
(~5.32 ppm). (B) Conditional silencing of the glgE gene in theM. smegmatis ΔtreS(u) ΔglgP(u)
c-glgE-tet-off mutant reveals no involvement of GlgP for alternative M1P synthesis. Cells were
cultivated for 24 h with or without 1 μg ml-1 ATc as indicated, and hot water extracts from 1
ml culture aliquots (normalized to OD600 nm = 0.5) were analyzed by TLC.
(TIF)
S3 Fig. (Semi)quantitative detection of α-glucan inM. smegmatismc2155 andM. tuberculo-
sisH37Rv mutant strains. (A) Detection of capsular and cytosolic glucan inM. smegmatis
mc2155 mutant strains. Cells were grown on Middlebrook 7H10 agar plates for 3 days. Extra-
cellular (i.e. capsular) and cytosolic glucan were extracted, and aliquots of extracts were ana-
lyzed by dot blot employing an α-glucan-specific monoclonal antibody as described previously
[49]. (B) Detection of cytosolic α-glucan inM. tuberculosisH37Rv mutant strains using an
enzymatic method. Cells were grown in Middlebrook 7H9 liquid medium for 7 days with shak-
ing and α-glucan from hot water cytosolic extracts was quantified using an enzymatic method.
Errors represent the SEM of three experimental replicates. Values were normalized based on
the OD600 nm of cultures. Similar results were obtained with independent biological replicates
using a sandwich ELISA method (Fig 4).
(TIF)
S4 Fig. TheM. tuberculosis ΔglgC(u) ΔotsAmutant is a trehalose auxotroph despite the
presence of Rv3032. Trehalose auxotrophy implies that it is devoid of α-glucans usable as sub-
strates for trehalose biosynthesis via the TreX-TreY-TreZ pathway. Cells were cultivated on
Middlebrook 710 agar plates with or without 500 μM trehalose for 21 days.
(TIF)
S1 Table. Strains ofM. smegmatismc2155 used in this study.Mutants were generated by alle-
lic exchange employing specialized transduction using mycobacteriophages listed in S3 Table.
Abbreviations: Kanr, kanamycin resistant; Hygr, hygromycin resistant; Aprar, apramycin resis-
tant; (u), unmarked mutant.
(PDF)
S2 Table. Strains ofM. tuberculosisH37Rv used in this study.Mutants were generated by
allelic exchange employing specialized transduction using mycobacteriophages listed in S3
Table. Abbreviations: Hygr, hygromycin resistant; (u), unmarked mutant.
(PDF)
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S3 Table. Oligonucleotides used for generation of allelic exchange substrates. The phages
listed here were used for the generation of either gene deletion mutants ofM. smegmatis
mc2155 andM. tuberculosisH37Rv or of knock-in mutants ofM. smegmatismc2155 (phc-
MSMEG_4916–4×tetO) listed in S1 and S2 Tables by specialized transduction.
(PDF)
S1 Text. Nucleotide sequence of plasmid pcRv1327c-4XtetO. Vector arms used for generat-
ing the allelic exchange substrate to establish regulated expression of glgE inM. smegmatis are
highlighted in grey. Van91I restriction sites are underlined.
(PDF)
S2 Text. Nucleotide sequence of plasmid pMV261-RBS-G. The modified ribosome binding
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